Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yue Xue Xia
Observed name:
Yue Xia
Institutions:
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
Observed institutions:
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China,
Northeast Forestry University
ORCID:
0009-0001-8487-8800
Observed ORCID:
0009-0001-8487-8800
OpenAlex ID:
A5065987877
Fabrication and performance of a spherical cellulose nanocrystal-based hydrophobic drug delivery vehicle using rubber wood
2019
·
Dingyuan Zheng
, Yating Deng
, et al.
·
BioResources
·
17
Hi-Fi Stake Piezo Single Crystal Actuator
2018
·
Yu Huang
, Shuangjie Zhang
, et al.
·
Actuators
·
12
PDF
High-Bending-Stiffness Connector (HBSC) and High-Authority Piezoelectric Actuator (HAPA) Made of Such
2018
·
Yu Huang
, Yue Xue Xia
, et al.
·
Actuators
·
5
PDF
Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
·
Clinical Cancer Research
·
2
PDF
The role of immunochemotherapy maintenance in metastatic nasopharyngeal carcinoma: insights from a cohort study in an endemic region
2025
·
Zhuoying Luo
, Yue Xia
, et al.
·
Clinical & Translational Immunology
·
1
PDF
Data from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Supplementary Method 2 from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Supplementary Table 4 from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Supplementary Method 1 from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Supplementary Figure 1 from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Supplementary Table 2 from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Supplementary Table 7 from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Supplementary Table 5 from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Supplementary Table 3 from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Supplementary Table 6 from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Supplementary Table 1 from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Supplementary Data 1 from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Supplementary Table 8 from Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
2025
·
Xun Cao
, Zhuo-Ying Luo
, et al.
Optimal maintenance therapy strategy for metastatic nasopharyngeal carcinoma: Insights from a cohort study in an endemic region.
2025
·
Zhuoying Luo
, Yue Xia
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
19
Citation count:
37
H-index:
3
I10-index:
2
Year
Topic
Type